|Last Price$46.72||Day Change (%)-0.45%|
|Open Price$46.82||Day Change ($)-0.21|
|Day Range45.82–46.92||52-Week Range37.59–58.05|
As of Thu 7/28/2016 5:00:00 PM | USD
FTC give go-ahead for Mylan's $7.2 billion purchase of Meda
Watson Pharmaceuticals WPI scored big Tuesday when the Food and Drug Administration approved the firm's generic fentanyl patch. We may modestly increase our fair value estimate for Watson and will maintain our fair value estimate for competitor Mylan Laboratories MYL . The pain patch is one of the ...
Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...
MEDA: Interim Report, January-June 2016
Abbott Results, Helped by Product Launches, Top Views
Valeant Chief Vows 'New Chapter' -- WSJ
July 18 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Perrigo Company plc